Introduction: The aim of this study is the evaluation of the effect of Antimicrobial Photodynamic Therapy with Radachlorin on Staphylococcus aureus and Escherichia coli.
New windows are open in the antimicrobial field so-call Photodynamic therapy that incorporates a nonpoisonous photosensitizer (PS) with innocuous special wavelength photons to excite the PS.
Methods: Two strains of bacteria used in this study were Methicillin resistant Staphylococcus aureus (ATCC 33591; PTCC 1764) and Escherichia coli (ATCC 25922; PTCC1399). Concentrations of 0.2 ml of Radachlorin® were applied on 0.2 ml of bacterial suspensions and placed in a 48-well microtiter plate. The following groups were used: (I) L− PS− (no laser, no photosensitizer), (II) L−PS+ (treated only with PS), (III) L+ PS− (treated only with laser) and (IV) L+ PS+ (treated with laser and PS: photodynamic therapy group). Aliquots of bacterial suspensions were sensitized with Radachlorin® for 15 minutes in the dark at room temperature and then bacterial suspensions in group III and IV were irradiated with 210 mW (power density) and 12 J/cm2 (energy density) on continuous mode.
Results: This study showed that photodynamic therapy reduces 0.14 log 10 in E.Coli (group IV) and there were significant differences for group IV (P<0.01). Photodynamic therapy in S.Aureus showed 6.28 log 10 colony count reduction (group IV) and there were highly significant differences in Photodynamic therapy group (P<0.0001).
Conclusion: Radachlorin® have bactericidal effect on S.aureus (6.28 log 10) and bacteriostatic effect on E.coli (0.14 log 10).
Bootsma MC, Diekmann O, Bonten MJ. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci 2006; 103: 5620-5.
Giamarellou H. Multidrug resistance in Gram-negative bacteria that produce extended spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 2005; 11 Suppl 4: 1-16.
Kang J, Sickbert-Bennett EE, Brown VM, Weber DJ, Rutala WA. Relative frequency of health care-associated pathogens by infection site at a university hospital from 1980 to 2008. Am J Infect Control 2012; 40: 416-20.
Underwood J, Klein JL, Newsholme W. Escherichia coli bacteraemia: how preventable is it? J Hosp Infect 2011; 79: 364-5.
Liu ZZ, Xiong YL, Fan XJ, Gao YY, Yu RJ. The correlation between expression level of femB and resistance phenotype of methicillin-resistant Staphylococcus aureus (MRSA). Sichuan Da Xue Xue Bao Yi Xue Ban 2011; 42: 661-5.
Ana P Castano, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part one photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004; 1: 279-93.
Tegos GP, Masago K, Aziz F, Higginbotham A, Stermitz FR, Hamblin MR. Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation. Antimicrob Agents Chemother 2008; 52: 3202-9.
Drulis-Kawa Z, Bednarkiewicz A, Bugla-Ploskonska G, Strek W, Doroszkiewicz W. The susceptibility of anaerobic bacteria isolated from periodontal diseases to photodynamic inactivation with Fotolon (chlorin e6). Pol J Microbiol 2005; 54: 305-10.
Gad F, Zahra T, Hasan T, Hamblin MR. Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother 2004; 48:2173-8.
Hamblin MR, O'Donnell DA, Murthy N, Rajagopalan K, Michaud N, Sherwood ME, et al. Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J Antimicrob Chemother 2002; 49: 941-51.
Jeong H, Huh M, Lee SJ, Koo H, Kwon IC, Jeong SY, et al. Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy. Theranostics 2011; 1: 230-9.
Tang HM, Hamblin MR, Yow CM. A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens. J Infect Chemother 2007; 13: 87-91.
Privalov VA, Seliverstov OV, Revel'-Muroz Z, Lappa AV, Demidov AK, Faĭzrakhmanov AB. Percutaneous laser-induced thermotherapy of nodular goiter. Khirurgiia (Mosk) 2001; 1:10-3.
Fekrazad R, Bargrizan M, Sajadi S. Evaluation of the effect of photoactivated disinfection with Radachlorin (R) against Streptococcus mutans (an in vitro study). Photodiagn Photodyn Ther 2011; 8: 249-53.
Vahabi S, Fekrazad R, Ayremlou S, Taheri S, Zangeneh N. The effect of antimicrobial photodynamic therapy with radachlorin and toluidine blue on streptococcus mutans: an in vitro study. J Dent Tehran 2011; 8: 48-54.
Stegemann MR, Sherington J, Blanchflower S. Pharmacokinetics and pharmacodynamics of cefovecin in dogs. J Vet Pharmacol Ther 2006; 29: 501-11.
Malik Z, Hanania J, Nitzan Y. Bactericidal effects of photoactivated porphyrins--an alternative approach to antimicrobial drugs. J Photochem Photobiol 1990; 5: 281-93.
Bertoloni G, Salvato B, Dall'Acqua M, Vazzoler M, Jori G. Hematoporphyrin-sensitized photoinactivation of Streptococcus faecalis. Photochem Photobiol 1984; 39:811-6.
Park JH, Moon YH, Bang IS, Kim YC, Kim SA, Ahn SG, et al. Antimicrobial effect of photodynamic therapy using a highly pure chlorin e6. Lasers Med Sci 2010; 25: 705-10.
Fomichev AI, Zorin VP, Zorina TE, Cherenkevich SN. Photodamage of gram-positive and gram-negative bacterial cells in the presence of chlorin e6 derivatives. Mikrobiologiia 1991; 60: 507-11.
Hope CK, Packer S, Wilson M, Nair SP. The inability of a bacteriophage to infect Staphylococcus aureus does not prevent it from specifically delivering a photosensitizer to the bacterium enabling its lethal photosensitization. J Antimicrob Chemother 2009; 64: 59-61.
Luan XL, Qin YL, Bi LJ, Hu CY, Zhang ZG, Lin J, et al. Histological evaluation of the safety of toluidine blue-mediated photosensitization to periodontal tissues in mice. Lasers Med Sci 2009; 24: 162-6.